Ca-AKG, calcium salt of alpha-ketoglutarate, TCA cycle intermediate · Evidence-based safety and harm-reduction overview.
| Also known as | Ca-AKG, calcium salt of alpha-ketoglutarate, TCA cycle intermediate |
| Category | Supplement |
| tca_cycle_intermediate | True |
| epigenetic_modifier | True |
| human_trial_data | minimal and unpublished |
| bioavailability_challenge | poor oral absorption |
| US legal status | Sold as dietary supplement in the USA (DSHEA). Not FDA-approved as drug. Available over-the-counter. Limited regulatory oversight; quality varies by manufacturer. |
A calcium salt form of alpha-ketoglutarate, a TCA cycle intermediate. Proposed to support cellular energy production and mitochondrial function. Intracellular AKG is involved in the NAD+/NADH ratio and histone acetylation (epigenetic aging markers).
AKG is a TCA cycle intermediate and cofactor for alpha-ketoglutarate-dependent dioxygenases (TET enzymes, prolyl hydroxylases). Involved in epigenetic modification (histone/DNA methylation) and histone deacetylase regulation. Proposed to reverse aging via epigenetic reprogramming.
AKG and aging studied since 2016 (Buck Institute). Used as supplement precursor; limited commercialization. Very few human trials. Mostly preclinical evidence in C. elegans and cell culture.
Preclinical studies (cell culture, rodent models) suggest AKG improves mitochondrial respiration and extends lifespan in C. elegans (a model organism). Very limited human data; one small unpublished trial suggested improved muscle mass. Evidence is preliminary; human efficacy not established.
Animal studies use high doses (1000-2000 mg/kg). Human supplement doses range 1000-3000 mg daily. No optimal dose established; bioavailability is poor and highly variable.
This is general research/context information, not medical advice or a recommended protocol.
Ca-AKG may stack with other NAD+-dependent pathways (NMN, NR) or epigenetic modulators (resveratrol) but combinations are untested in humans; avoid stacking with other AKG sources or high-dose calcium.
If you are going to research a compound, verifying identity and purity is the single most protective step. Independent analytical testing and sterile-handling supplies reduce risk.
Compare testing optionsPreclinical studies suggest mitochondrial benefits. No human clinical trials published; efficacy in humans is unproven.
Both are salts of alpha-ketoglutarate with similar proposed mechanisms. Calcium form is more common in supplements; sodium form used in research. Relative efficacy unknown.
AKG is produced endogenously from amino-acid metabolism; dietary sources are minimal. Exogenous supplementation aims to increase intracellular AKG.
One gram of Ca-AKG provides ~130 mg elemental calcium. High-dose use may contribute to total daily calcium; avoid if already supplementing or using high-dose calcium.
Medical & legal disclaimer. This site is for informational and harm-reduction purposes only. It is not medical advice and is not a substitute for a licensed healthcare professional. The compounds discussed are largely not approved by the FDA for human use and many are sold strictly as research chemicals 'not for human consumption.' Nothing here is an endorsement to purchase, possess, or use any substance. Laws vary by jurisdiction. Always consult a qualified physician and follow the law where you live.
Some links on this page may be affiliate links. If you buy through them we may earn a commission at no extra cost to you. This never changes the safety information we publish.